Condition 1: Ulcerative Colitis. Condition 2: Crohn Disease. Ulcerative colitis Crohn's disease [regional enteritis]
Conditions
Interventions
Intervention 1: The method of intervention in the experimental group is education and disease management via mobile phone for 6 months so that it can be trained through educational intervention with p
Sponsors
Mashhad University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: Diagnosis of inflammatory bowel disease based on internationally accepted diagnostic criteria including clinical signs, endoscopic findings, radiological and histological studies by a physician specializing in gastroenterology and adult liver Minimum age 18 years Willingness to enter the study and complete informed written consent Ability to access and use smart phones and the Internet Ability to read and write in Persian Patients with at least one week on remission Not receiving self-management and education-oriented programs at the same time and participating in another experimental study when registering a patient
Exclusion criteria
Exclusion criteria: Inability to communicate with and match with researchers Reluctance to continue cooperation Pregnancy Active perianal or anal abscess disease Existence of an anastomosis of the bladder Participate in another experimental study that may interfere with this study Having other chronic and acute diseases diagnosed by a doctor such as liver, kidney, circulatory system and acute mental disorder
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Quality of life index. Timepoint: At the beginning of the study, 3 and 6 months after the intervention. Method of measurement: will be measured by a 32-item Inflammatory Bowel Disease Questionnaire.;Disease activity index. Timepoint: At the beginning of the study, 3 and 6 months after the intervention. Method of measurement: Harvey-Bradshaw Index (HBI) for Crohn's disease and Simple Clinical Colitis Activity Index (SCCAI) for Ulcerative Colitis patients.;Hospital Anxiety and Depression. Timepoint: At the beginning of the study, 3 and 6 months after the intervention. Method of measurement: Hospital Anxiety and Depression Scale (HADS). | — |
Secondary
| Measure | Time frame |
|---|---|
| Self-Efficacy Scale. Timepoint: At the beginning of the study, 3 and 6 months after the intervention. Method of measurement: IBD Self-efficacy Scale.;Measure non-adherence. Timepoint: At the beginning of the study, 3 and 6 months after the intervention. Method of measurement: Morisky Medication Adherence Scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactNarges Norouzkhani
Mashhad University of Medical Sciences
Outcome results
None listed